Aju Ib Investment Co., Ltd. / KYMR
Aju Ib Investment Co., Ltd.’s Kymera Therapeutics Inc Position
Does Aju Ib Investment Co., Ltd. own Kymera Therapeutics Inc (KYMR)? Yes — 19.6K shares worth $2M (+5.36% of its 13F portfolio) as of Q1 2026.
Position Value
$2M
Q1 2026
Shares
19.6K
% of Portfolio
+5.36%
Quarters Held
12
currently held
Position History KYMR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 19.6K | $2M | +5.36% |
| Q4 2025 | 19.6K | $2M | +6.71% |
| Q3 2025 | 457.1K | $26M | +22.47% |
| Q2 2025 | 457.1K | $20M | +21.71% |
| Q1 2025 | 457.1K | $13M | +14.88% |
| Q3 2022 | 457.1K | $10M | +17.03% |
| Q2 2022 | 457.1K | $9M | +17.42% |
| Q1 2022 | 457.1K | $19M | +29.87% |
| Q4 2021 | 457.1K | $29M | +40.43% |
| Q3 2021 | 639.1K | $38M | +24.22% |
| Q2 2021 | 639.1K | $31M | +17.87% |
| Q1 2021 | 639.1K | $25M | +9.37% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aju Ib Investment Co., Ltd.’s full portfolio or all institutional holders of KYMR.